The generic name of Enalapril is Enalcip, and the difference between Enalapril and Adalimumab mainly lies in the drug composition, indications, dosage and other aspects. 1. Composition: etanercept is essentially a humanized receptor-antibody fusion protein, while adalimumab is a fully humanized monoclonal antibody. However, both are tumor necrosis factor inhibitors. 2. Indications: The indications of etanercept are rheumatoid arthritis and ankylosing spondylitis, while the indications of adalimumab are rheumatoid arthritis, ankylosing spondylitis, psoriasis and Crohn’s disease. 3. Dosage: The recommended dosage of etanercept injection for the treatment of rheumatoid arthritis and ankylosing spondylitis is 25mg twice a week or 50mg once a week, while the recommended dosage of adalimumab for the treatment of rheumatoid arthritis and ankylosing spondylitis is 40mg once every two weeks, and the specific usage of the drug varies according to the specific disease, condition, and individual physical condition. Etanercept and adalimumab need to be used under the guidance of a physician, it is recommended that patients who need to use these two drugs to the rheumatology and immunology department of a regular hospital for detailed consultation.